MedTrace Logo

A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery

NCT00500669 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-04-12

No results posted yet for this study

Summary

To investigate whether Betadine can reduce infection rates and recurrence rates following varicose veins surgery in a randomized double blind placebo controlled study.

Conditions

  • Varicose Veins
  • Wound Infection
  • Recurrence

Interventions

DRUG

Betadine

Topically

Sponsors & Collaborators

  • Royal Hobart Hospital

    lead OTHER_GOV

Principal Investigators

  • Stuart Walker, MBBS · Royal Hobart Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00500669 on ClinicalTrials.gov